Abstract Search

ey0018.11-11 | Criticism of the previous BMI metrics for use in severely obese children | ESPEYB18

11.11. Evaluation of BMI metrics to assess change in adiposity in children with overweight and moderate and severe obesity

SE Barlow , M Salahuddin , C Durand , SJ Pont , DM Hoelscher , NF Butte

Obesity (Silver Spring) 2020 Aug;28(8):1512–1518. https://pubmed.ncbi.nlm.nih.gov/32935936/These authors analysed a cohort of n=399 overweight and obese children (age 212 years), who underwent a 1-year lifestyle intervention, to test whether possible alternatives to the BMI z-score (%BMIp95, %BMIp50, BMImz) might correlate better with changes in % total body fat (%BF) a...

0 shares

ey0015.11-12 | Hungry fat cells | ESPEYB15

11.12 Asprosin is a centrally acting orexigenic hormone

C Duerrschmid , Y He , C Wang , C Li , JC Bournat , C Romere , PK Saha , ME Lee , KJ Phillips , M Jain , P Jia , Z Zhao , M Farias , Q Wu , DM Milewicz , VR Sutton , DD Moore , NF Butte , MJ Krashes , Y Xu , AR Chopra

To read the full abstract: Nat Med. 2017 Dec; 23(12): 1444–1453This study highlights the importance of asprosin in the regulation of appetite. This peptide hormone was first described by Romere et al. in 2016 (1), who reported 2 patients with neonatal progeroid syndrome (NPS) due to truncating heterozygous mutations in the fibrillin-gene (FBN1). The FBN1 gene encodes profibrillin wh...

0 shares

ESPE Yearbook of Paediatric Endocrinology

11.11. Evaluation of BMI metrics to assess change in adiposity in children with overweight and moderate and severe obesity

11.12 Asprosin is a centrally acting orexigenic hormone

BiosciAbstracts